MicroProbe Corp., of Bothell, Wash., appointed Fred Craves, thecompany's chairman of the board, as chief executive officer. Hereplaces Harvey Hoyt, who resigned.Daniel Magilavy was named as director of medical research for BiogenInc., of Cambridge, Mass.Cambridge Neuroscience Inc. appointed former Merck ResearchLaboratories director, Gilbert Block, as vice president, clinicaldevelopment.BioSepra Inc., of Marlborough, Mass., announced the appointment ofDouglass Greenlaw as chief financial officer and vice president offinance.GeneMedicine Inc., of Houston, appointed Kathryn Stankis as vicepresident of administration and human resources.Amgen, of Thousand Oaks, Calif., named Robert Attiyeh, a seniorpartner with McKinsey & Co. Inc., of Los Angeles, as senior vicepresident, finance and corporate development.Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed BernhardPalsson as vice president of developmental research.Patrice Coissac was appointed president of Boehringer MannheimFrance Pharma SA.Human Genome Sciences Inc., of Rockville, Md., named MichaelAntonaccio as vice president of strategic drug development.Genetics Institute Inc., of Cambridge, Mass., named Thomas DesRosieras vice president and chief patent counsel.Paul Broome was appointed as vice president and medical director forclinical trials and regulatory affairs for Aphton, of Woodland, Calif.

(c) 1997 American Health Consultants. All rights reserved.